Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

U.S. insulin costs per patient nearly doubled from 2012 to 2016: study


The cost of insulin for treating type 1 diabetes in the United States nearly doubled over a five-year period, underscoring a national outcry over rising drug prices, according to a new analysis shared with Reuters. (Reuters US News) More More

Similar stories

Diabetics Waiting For Relief As Insulin Prices Nearly Double Over 5-Year Span - CBS Philly

Diabetics Waiting For Relief As Insulin Prices Nearly Double Over 5-Year Span  CBS Philly

PHILADELPHIA (CBS) — Some pharmaceutical companies have pledged to try to contain high prices of insulin, but patients with diabetes are still waiting for ...

Posted on 17 April 2019 | 5:48 pm | Google News

Hartland family with 3 diabetic kids endures rising insulin prices - WDJT

Hartland family with 3 diabetic kids endures rising insulin prices  WDJT

MILWAUKEE (CBS 58) -- The rising cost of insulin is now considered a serious health crisis, with Washington D.C. lawmakers pushing pharmaceutical ...

Posted on 16 April 2019 | 9:48 pm | Google News

Rising costs of diabetes medications makes management a challenge for many patients - Albert Lea Tribune - Albert Lea Tribune

Rising costs of diabetes medications makes management a challenge for many patients - Albert Lea Tribune  Albert Lea Tribune

Thank you for supporting local journalism and your community! We hope you enjoy 10 free stories each month and we invite you to subscribe to unlimited digital ...

Posted on 16 April 2019 | 7:56 pm | Google News

Market Survey: Insulin Delivery Devices Market is expected to grow at a CAGR of 10% during the forecast period of(2018 – 2023) - Akron Daily

Market Survey: Insulin Delivery Devices Market is expected to grow at a CAGR of 10% during the forecast period of(2018 – 2023)  Akron Daily

Report Title: “Global Insulin Delivery Devices Market – Segmented by Type, End User, and Geography – Growth, Trends, and Forecast (2018 – 2023)”.

Posted on 14 April 2019 | 9:42 am | Google News

The next 100 days: the sky's the limit - Roll Call

The next 100 days: the sky's the limit  Roll Call

OPINION — One hundred days ago, I stood with my fellow House Democrats and swore the oath of office. We raised our right hands and promised to uphold the ...

Posted on 12 April 2019 | 9:39 am | Google News

Column: Drug companies try shifting blame for high prices under lawmakers’ scrutiny - PBS NewsHour

Column: Drug companies try shifting blame for high prices under lawmakers’ scrutiny  PBS NewsHour

Rising insulin prices are once again shining an uncomfortable spotlight on drug-company CEOs, who have been dutifully taking a public pounding before ...

Posted on 11 April 2019 | 2:00 am | Google News

Copyright © 2019 LastMinuteStuff.com
Contact info